Skip to NavigationSkip to content

3d printing

Featured market report: 3D printing market summary

Published on 02/11/15 at 03:28pm
3D printer
Credit: Jonathan Juursema

The global 3D printing medical devices market is estimated to grow at a CAGR of 25.3% from 2015 to 2020.

The 3D printing market is set for unprecented growth: driven by factors such as continuous technological advancements in 3D printing, rising government financial support to develop novel healthcare applications of 3D printing technology, ability to develop customized medical products using 3D printing technology, and growing acceptance of 3D-printed organs in organ

It’s finally here: 3D-printed pills and technology in pharma

Published on 29/09/15 at 11:07am
3D printer
Credit: Jonathan Juursema

The notion of tailor-made drugs, which are customised to an individual patient’s needs, has seen remarkable progress of late. This has culminated in the achievement of recent ground-breaking pharma innovation in the area of technology known as three dimensional (3D) printing.

First 3D-printed drug approved by FDA

Spritam
Aprecia's epilepsy treatment is the first approved 3D printed drug

The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a 3D-printed drug for medical use.

3D-printed (3DP) medical products, including prosthetics, have previously been approved by the administration, but Aprecia's epilepsy treatment Spritam (levetiracetam) is the first to get the nod for use in the human body.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches